Abiomed Inc (ABMD.O)

ABMD.O

About

ABIOMED, Inc. develops temporary and permanent cardiac support systems. The Company develops, manufactures and markets medical technologies designed to assist or replace the pumping function of the failing heart. It focuses on the development of two temporary support systems, the bi-ventricular support system (BVS) and the... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	1.44
Market Cap (Mil.):	$862.63
Shares Outstanding (Mil.):	38.74
Dividend:	--
Yield (%):	--

Financials

	ABMD.O	Industry	Sector
P/E (TTM):	60.93	72.35	33.02
EPS (TTM):	0.37	--	--
ROI:	10.94	4.69	19.07
ROE:	11.40	9.78	20.00

Latest News about ABMD.O

BRIEF-Abiomed shares up 7.2 pct, volume high

NEW YORK, April 17 - Abiomed Inc : * Shares up 7.2 percent, volume above 25-day average

17 Apr 2013

» More ABMD.O News

Competitors

	Price	Change
Terumo Corp (4543.T)	¥5,060	+60.00
Getinge AB (GETIb.ST)	204.70kr	-0.20
Teleflex Incorporated (TFX.N)	$78.50	+1.01
Thoratec Corporation (THOR.OQ)	$31.82	+0.51
HeartWare International Inc (HTWR.OQ)	$96.17	+1.06
MicroMed Cardiovascular, Inc. (MMCO.PK)	$6,400.00	0.00

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
ValuEngine Industry Report for Medical Instruments Provider: ValuEngine, Inc.	$196.00 Buy
Thomson Reuters Stock Report - ABIOMED, INC. (ABMD-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
ABIOMED INC (ABMD) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Abiomed Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ABIOMED INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. Provider: Jefferson Research	$20.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.